Therefore, we acknowledge that the regulatory landscape of NR0B1 is multifactorial, and further studies are warranted to dissect these alternative regulatory mechanisms in the context of KEAP1-mutant lung adenocarcinoma. This evidence concerns the gene NR0B1 and lung adenocarcinoma.